Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06A ANTIBIOTICS FOR TOPICAL USE
D06AX Other antibiotics for topical use
D06AX14 Ozenoxacin
D09544 Ozenoxacin (JAN/USAN/INN) <JP>
USP drug classification [BR:br08302]
Dermatological Agents
Topical Anti-infectives
Antibacterials, Dermatological
Ozenoxacin
D09544 Ozenoxacin (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
263 Suppurative dermatosis agents
2639 Others
D09544 Ozenoxacin (JAN/USAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
D09544 Ozenoxacin
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09544 Ozenoxacin
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Other quinolone
D09544 Ozenoxacin (JAN/USAN/INN) <JP>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Other quinolone
D09544 Ozenoxacin (JAN/USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09544
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09544
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09544
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09544